Oaktree Capital-backed Oaktree Acquisition to merge with Hims in a $1.6bn deal.

Oaktree Capital-backed Oaktree Acquisition, a special purposes acquisition vehicle, agreed to merge with Hims, a telehealth company, in a $1.6bn deal. Upon completion of the transaction, the combined company’s securities are expected to be traded on the New York Stock Exchange under the symbol “HIMS.” “We’re thrilled to partner with Oaktree Acquisition to usher Hims & Hers into our next phase of growth as we work to become the front door to the healthcare system, serving as the first stop for peoples’ health and wellness needs across hundreds of conditions. Hims & Hers was founded to make it easier and more affordable for everyone to get the healthcare they need. We remain committed to advancing that goal as we expand into new categories of care and build an enduring healthcare company that brings choice, affordability and access to consumers," Andrew Dudum, Hims Founder and CEO.